Cargando…
Feasibility of sleeve lobectomy after neo-adjuvant chemo-immunotherapy in non-small cell lung cancer
Immunotherapy is one of the most effective treatments for patients with advanced lung cancer. In many advanced non-small cell lung cancer (NSCLC) cases, the tumor is centrally located. For such patients, sleeve lobectomy has been considered as a more effective therapeutic option compared with pneumo...
Autores principales: | Chen, Yulong, Zhang, Lianmin, Yan, Bo, Zeng, Ziqing, Hui, Zhenzhen, Zhang, Ran, Ren, Xiubao, You, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354158/ https://www.ncbi.nlm.nih.gov/pubmed/32676337 http://dx.doi.org/10.21037/tlcr-20-539 |
Ejemplares similares
-
Survival benefit and toxicity profile of adjuvant icotinib for patients with EGFR mutation-positive non-small cell lung carcinoma: a retrospective study
por: Zeng, Ziqing, et al.
Publicado: (2020) -
Successful Downstaging of High Rectal and Recto-Sigmoid Cancer by Neo-Adjuvant Chemo-Radiotherapy
por: O’Neill, Brian, et al.
Publicado: (2008) -
High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy
por: Papagrigoriadis, S
Publicado: (2006) -
The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma
por: Dibajnia, Pooya, et al.
Publicado: (2023) -
Dramatic response of metaplastic breast cancer to chemo-immunotherapy
por: Adams, Sylvia
Publicado: (2017)